Evidence map›Paper›PMID 34122616›Full record

ArticleComputational and mathematical methods in medicine2021

Ghrelin Regulates Cyclooxygenase-2 Expression and Promotes Gastric Cancer Cell Progression.

Huanqing Li, Xiaohong Zhang, Li Feng

Open access · hybridAbstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Huanqing LiEndoscopy Center, Minhang District Central Hospital of Fudan University, Shanghai, China.
Xiaohong ZhangEndoscopy Center, Minhang District Central Hospital of Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0001-5419-0899
Li FengEndoscopy Center, Minhang District Central Hospital of Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-5309-8975
Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo research the molecular mechanism of ghrelin in apoptosis, migratory, and invasion of gastric cancer (GC) cells.

methodsAfter GC AGS cells were handled with ghrelin (10

resultsThe migratory and invasion were increased in ghrelin-treated cells, while the rates of apoptosis were decreased. GC AGS cells treated with ghrelin showed an increase in protein expression of p-Akt, PI3K, and COX-2. After cells were treated with Akt inhibitor perifosine, the protein expression of p-Akt, PI3K, and COX-2 and the cell migratory, invasion, and apoptosis were partly recovered. After cells were treated with cyclooxygenase-2 inhibitor NS398, the protein expression of COX-2 and the cell migratory and invasion were decreased, while the rates of apoptosis were increased.

conclusionGhrelin regulates cell migration, invasion, and apoptosis in GC cells through targeting PI3K/Akt/COX-2. Ghrelin increases the expression of COX-2 in GC cells by targeting PI3K/Akt. Ghrelin is suggested to be one of the molecular targets in GC.

Indexed as

ApoptosisCell Line, TumorCell MovementComputational BiologyCyclooxygenase 2Cyclooxygenase 2 InhibitorsDisease ProgressionGhrelinHumansNeoplasm InvasivenessNitrobenzenesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionStomach NeoplasmsSulfonamidesCyclooxygenase 2Cyclooxygenase 2 InhibitorsGhrelinN-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamideNitrobenzenesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTGS2 protein, humanSulfonamides

Identifiers

PMID34122616
PMCPMC8166482
OpenAlexW3165785886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.